Astellas Gene Therapies
Part of Astellas Pharma
CompanyUnited States
Astellas Gene Therapies develops one asset. Mostly gene therapy; based in the United States.
- 1
- Asset
- Furthest stage
- Not known
- 2
- Trials
- 0
- Signals
Pipeline
1Delivers a functional frataxin gene to restore mitochondrial function in heart muscle cells.
Stage not known, Gene therapy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials2
- Deals1
- Similar companies6